Accustem Sciences Current Debt
ACUT Stock | USD 0.36 0.03 9.09% |
Accustem Sciences' financial leverage is the degree to which the firm utilizes its fixed-income securities and uses equity to finance projects. Companies with high leverage are usually considered to be at financial risk. Accustem Sciences' financial risk is the risk to Accustem Sciences stockholders that is caused by an increase in debt. In other words, with a high degree of financial leverage come high-interest payments, which usually reduce Earnings Per Share (EPS).
Given that Accustem Sciences' debt-to-equity ratio measures a OTC Stock's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Accustem Sciences is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Accustem Sciences to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Accustem Sciences is said to be less leveraged. If creditors hold a majority of Accustem Sciences' assets, the OTC Stock is said to be highly leveraged.
Accustem |
Accustem Sciences Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Accustem Sciences' operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Accustem Sciences, which in turn will lower the firm's financial flexibility.Understaning Accustem Sciences Use of Financial Leverage
Accustem Sciences' financial leverage ratio measures its total debt position, including all of its outstanding liabilities, and compares it to Accustem Sciences' current equity. If creditors own a majority of Accustem Sciences' assets, the company is considered highly leveraged. Understanding the composition and structure of Accustem Sciences' outstanding bonds gives an idea of how risky it is and if it is worth investing in.
AccuStem Sciences, Inc. operates as a life sciences company focusing on improving outcomes for patients with cancer. It develops StemPrintER technology, a multi-gene prognostic assay to predict the risk of recurrence of Endocrine receptor-positive HER2- breast cancer and Spare, a derivative of StemPrintER that combines StemPrintER with two clinical markers. Accustem Sciences is traded on OTC Exchange in the United States. Please read more on our technical analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Accustem OTC Stock Analysis
When running Accustem Sciences' price analysis, check to measure Accustem Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Accustem Sciences is operating at the current time. Most of Accustem Sciences' value examination focuses on studying past and present price action to predict the probability of Accustem Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Accustem Sciences' price. Additionally, you may evaluate how the addition of Accustem Sciences to your portfolios can decrease your overall portfolio volatility.
What is Financial Leverage?
Financial leverage is the use of borrowed money (debt) to finance the purchase of assets with the expectation that the income or capital gain from the new asset will exceed the cost of borrowing. In most cases, the debt provider will limit how much risk it is ready to take and indicate a limit on the extent of the leverage it will allow. In the case of asset-backed lending, the financial provider uses the assets as collateral until the borrower repays the loan. In the case of a cash flow loan, the general creditworthiness of the company is used to back the loan. The concept of leverage is common in the business world. It is mostly used to boost the returns on equity capital of a company, especially when the business is unable to increase its operating efficiency and returns on total investment. Because earnings on borrowing are higher than the interest payable on debt, the company's total earnings will increase, ultimately boosting stockholders' profits.Leverage and Capital Costs
The debt to equity ratio plays a role in the working average cost of capital (WACC). The overall interest on debt represents the break-even point that must be obtained to profitability in a given venture. Thus, WACC is essentially the average interest an organization owes on the capital it has borrowed for leverage. Let's say equity represents 60% of borrowed capital, and debt is 40%. This results in a financial leverage calculation of 40/60, or 0.6667. The organization owes 10% on all equity and 5% on all debt. That means that the weighted average cost of capital is (.4)(5) + (.6)(10) - or 8%. For every $10,000 borrowed, this organization will owe $800 in interest. Profit must be higher than 8% on the project to offset the cost of interest and justify this leverage.Benefits of Financial Leverage
Leverage provides the following benefits for companies:- Leverage is an essential tool a company's management can use to make the best financing and investment decisions.
- It provides a variety of financing sources by which the firm can achieve its target earnings.
- Leverage is also an essential technique in investing as it helps companies set a threshold for the expansion of business operations. For example, it can be used to recommend restrictions on business expansion once the projected return on additional investment is lower than the cost of debt.